Google and the Alleged Ad Tech Monopolyby Lilu Anderson 22.09.2024Delve into Google's alleged dominance in the ad tech market and the complexities of the antitrust trial.
Google’s Ad Tech Changes and Antitrust Battleby Mark Eisenberg 13.09.2024Google's 2019 ad tech changes face scrutiny in U.S. antitrust trial, impacting publishers' ad revenue strategies.
Moderna Cuts R&D by $1.1B, Focus on Key Approvalsby Mark Eisenberg 12.09.2024Moderna shares dip as R&D spending reduces, focusing on FDA approval for 10 key products including RSV and cancer treatments.
Goldman Sachs Expands Asia M&A Leadership Teamby Mark Eisenberg 11.09.2024Goldman Sachs appoints three co-heads to boost M&A operations in Asia, enhancing regional deals and cross-border transactions.
Tapestry-Capri Merger: Pricing Strategy Insightsby Mark Eisenberg 11.09.2024Tapestry executive testifies potential price hikes, discounts changes in Michael Kors products amid merger talks.
Bank of America Clients Buy the Dip in U.S. Stocksby Mark Eisenberg 11.09.2024BofA clients invest $2.4B in U.S. equities during market dip, marking the largest inflows in nine weeks with a focus ...
Medera’s SPAC Merger Marks Rare Biotech Moveby Lilu Anderson 06.09.2024Medera aims for Nasdaq listing via SPAC to boost gene therapies, spotlighting rare biotech SPACs in 2024.
ArsenalBio Secures $325M with Regeneron, BMS Backingby Lilu Anderson 04.09.2024ArsenalBio raises $325M to advance solid tumor CAR-T therapies. Focus on kidney, prostate cancer with innovative genomic technology.
BofA Predicts Gold Prices to Reach $3,000 by 2025by Mark Eisenberg 04.09.2024Bank of America forecasts gold prices hitting $3,000 per ounce in 2025, driven by interest rates and central bank activity.
Nvidia’s Record Drop Hits US Futures Hardby Mark Eisenberg 04.09.2024US futures slip 0.1% amid Nvidia's record drop and economic concerns, with investors eyeing U.S. jobs report.